Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
JAMA|May 27, 1992
Psychoactive substance dependence among trauma center patientsC A Soderstrom, P C Dischinger, G S Smith, et al.Biological Psychiatry|June 1, 1997
Neurophysiological signs of cocaine dependence: increased electroencephalogram beta during withdrawalR I Herning, X Guo, W E Better, et al.Journal of Substance Abuse Treatment|April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependenceR B Rothman, D A Gorelick, S J Heishman, et al.The Western Journal of Medicine|June 1, 1981
Heroin addiction and pregnancyR A Bashore, J S Ketchum, K J Staisch, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1980
Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addictsD H Catlin, R E Poland, D A Gorelick, et al.Alcoholism, Clinical and Experimental Research|November 5, 1998
Screening trauma patients for alcoholism according to NIAAA guidelines with alcohol use disorders identification test questionsC A Soderstrom, P C Dischinger, T J Kerns, et al.Archives of General Psychiatry|April 25, 2001
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716M A Huestis, D A Gorelick, S J Heishman, et al.Journal of Analytical Toxicology|January 1, 1985
Detection of recent cannabis use by saliva delta 9-THC radioimmunoassayS J Gross, T E Worthy, L Nerder, et al.Annals of Internal Medicine|December 1, 1989
Myocardial ischemia during cocaine withdrawalK Nademanee, D A Gorelick, M A Josephson, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1996
Cocaine cross-sensitization to dopamine uptake inhibitors: unique effects of GBR12909G I Elmer, A Brockington, D A Gorelick, et al.Pageof 7